Search

everythinglearnresearchcommunity

for

Search:↓

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

COVID-19 can cause various skin issues, including rashes and lesions.

Interest in COVID-19 hair loss increased during COVID-19 surges, especially in higher-income countries.

The COVID-19 pandemic led to fewer dermatology patients, more stress-related skin conditions during the crisis, and a rise in contact dermatitis after, with ongoing concerns for public health and treatment delays.

Hydroxychloroquine might help prevent COVID-19, but more research is needed.

Some alopecia treatments might help treat COVID-19, but more research is needed.

The study concluded that different treatments reduced post-COVID symptoms over time and that factors like age, severity, and comorbidities affect symptom risk.

Many COVID-19 survivors continue to experience symptoms like fatigue and concentration problems after recovery, possibly needing rehabilitation.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

Antiandrogens might help prevent or treat COVID-19 by blocking the virus's entry into cells.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

MSC-derived exosomes can help treat COVID-19, hair loss, skin aging, and arthritis.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

In 2021, JAMA Dermatology published significant findings on skin conditions post-COVID vaccination, melanoma surveillance, atopic dermatitis treatments, and confirmed that sun protection does not harm bone health.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Organoid technology is advancing and entering commercial use, with applications in disease modeling, drug development, and personalized medicine.

Redefining drug dosages is crucial when repurposing them for new uses.

Skin emergency severity rises with other health issues and affects multiple organs; a new grading system can improve patient care.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Long COVID patients have more health issues than non-infected people.

Antibody treatments show promise for hair loss but need more research.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

The document concludes that proper treatment and management of plaque psoriasis in adolescents can improve their quality of life.

Asparagus racemosus and Withania somnifera can help reduce side effects of a cancer drug.

The document concluded that certain compounds might strongly bind to and potentially inhibit a key SARS-CoV-2 protein, but further testing is needed.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.